Prebiotic ingredient developer Clasado Biosciences has appointed Steven Riley to the position of Head of B2B and Corporate Marketing.
The appointment marks a step forward for the company, it says, which continues to expand its global presence as a standalone bioscience brand,. The business places a heavy focus on education surrounding the gut microbiome.
Per Rehné, CEO, Clasado Biosciences, commented: “We are delighted to welcome Steven to the Clasado Bioscience family. With many years of experience in our industry, he has an enviable track record of success when it comes to the large-scale marketing of functional ingredients, as well as finished consumer products.
”This combination means Steven has fantastic insight into not only what our B2B partners are looking for in an ingredient, but also what the end consumer wants. This fully realised end-to-end view of the supply chain, along with his impressive skill set, makes him an ideal fit our team at Clasado.”
Riley said: “The prebiotic market is one of the fastest-growing in the world as consumers get switched on to the benefits of a well-supported gut microbiome. Clasado has carved out a fantastic reputation in this emergent field, backed by an extremely strong team.
“I am pleased to join Clasado on its global commercial journey and I look forward to making my mark. The business is moving from strength to strength on a truly global scale and the market is gathering real momentum, which makes it a particularly exciting time to join the team.”
